Listed

10x Genomics, Inc.

TXGNasdaqCIK 1770787TechnologyFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$151.0m, Q2 FY2026
Operating income−$19.6m, Q2 FY2026
Net income−$17.9m, Q2 FY2026
10x Genomics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m154Revenue, Q3 FY2023, three months to 2023-09-30$153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure184Revenue, Q4 FY2023, three months to 2023-12-31$184.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure141Revenue, Q1 FY2024, three months to 2024-03-31$141.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure153Revenue, Q2 FY2024, three months to 2024-06-30$153.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure152Revenue, Q3 FY2024, three months to 2024-09-30$151.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure165Revenue, Q4 FY2024, three months to 2024-12-31$165.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure155Revenue, Q1 FY2025, three months to 2025-03-31$154.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure173Revenue, Q2 FY2025, three months to 2025-06-30$172.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure149Revenue, Q3 FY2025, three months to 2025-09-30$149.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure166Revenue, Q4 FY2025, three months to 2025-12-31$166.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure151Revenue, Q1 FY2026, three months to 2026-03-31$150.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure151Revenue, Q2 FY2026, three months to 2026-06-30$151.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Cost of revenue$m58.1Cost of revenue, Q3 FY2023, three months to 2023-09-30$58.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure68.2Cost of revenue, Q4 FY2023, three months to 2023-12-31$68.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure48.1Cost of revenue, Q1 FY2024, three months to 2024-03-31$48.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure48.9Cost of revenue, Q2 FY2024, three months to 2024-06-30$48.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure45.3Cost of revenue, Q3 FY2024, three months to 2024-09-30$45.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure54.1Cost of revenue, Q4 FY2024, three months to 2024-12-31$54.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure49.4Cost of revenue, Q1 FY2025, three months to 2025-03-31$49.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure47.8Cost of revenue, Q2 FY2025, three months to 2025-06-30$47.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure48.7Cost of revenue, Q3 FY2025, three months to 2025-09-30$48.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure53.0Cost of revenue, Q4 FY2025, three months to 2025-12-31$53.0m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure44.7Cost of revenue, Q1 FY2026, three months to 2026-03-31$44.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure38.5Cost of revenue, Q2 FY2026, three months to 2026-06-30$38.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Gross profit$m95.5Gross profit, Q3 FY2023, three months to 2023-09-30$95.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure116Gross profit, Q4 FY2023, three months to 2023-12-31$115.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure92.9Gross profit, Q1 FY2024, three months to 2024-03-31$92.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure104Gross profit, Q2 FY2024, three months to 2024-06-30$104.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure106Gross profit, Q3 FY2024, three months to 2024-09-30$106.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure111Gross profit, Q4 FY2024, three months to 2024-12-31$111.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure105Gross profit, Q1 FY2025, three months to 2025-03-31$105.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure125Gross profit, Q2 FY2025, three months to 2025-06-30$125.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure100Gross profit, Q3 FY2025, three months to 2025-09-30$100.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure113Gross profit, Q4 FY2025, three months to 2025-12-31$113.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure106Gross profit, Q1 FY2026, three months to 2026-03-31$106.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure112Gross profit, Q2 FY2026, three months to 2026-06-30$112.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Selling, general and administrative$m82.4Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$82.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure86.1Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$86.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure85.8Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$85.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure83.0Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$83.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure81.7Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$81.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure93.8Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$93.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure89.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$89.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure74.4Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$74.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure75.4Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$75.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure76.6Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$76.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure66.4Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$66.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure78.7Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$78.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Operating income$m(94.8)Operating income, Q3 FY2023, three months to 2023-09-30−$94.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure(55.2)Operating income, Q4 FY2023, three months to 2023-12-31−$55.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure(61.5)Operating income, Q1 FY2024, three months to 2024-03-31−$61.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure(41.7)Operating income, Q2 FY2024, three months to 2024-06-30−$41.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure(41.5)Operating income, Q3 FY2024, three months to 2024-09-30−$41.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure(49.8)Operating income, Q4 FY2024, three months to 2024-12-31−$49.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure(39.3)Operating income, Q1 FY2025, three months to 2025-03-31−$39.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure30.1Operating income, Q2 FY2025, three months to 2025-06-30$30.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure(32.2)Operating income, Q3 FY2025, three months to 2025-09-30−$32.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure(19.5)Operating income, Q4 FY2025, three months to 2025-12-31−$19.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure(17.0)Operating income, Q1 FY2026, three months to 2026-03-31−$17.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure(19.6)Operating income, Q2 FY2026, three months to 2026-06-30−$19.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-03, accession 0001770787-23-000053.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$8.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-15, accession 0001770787-24-000017. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2024, three months to 2024-03-31$1.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-04-30, accession 0001770787-24-000036.Report this figure0.0Interest expense, Q2 FY2024, three months to 2024-06-30$1.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-30$2.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure0.0Interest expense, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure0.0Interest expense, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$3.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure(0.0)Interest expense, Q3 FY2025, three months to 2025-09-30−$3.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Interest expense, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Income tax$m1.2Income tax, Q3 FY2023, three months to 2023-09-30$1.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure2.4Income tax, Q4 FY2023, three months to 2023-12-31$2.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure2.1Income tax, Q1 FY2024, three months to 2024-03-31$2.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure0.8Income tax, Q2 FY2024, three months to 2024-06-30$818.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure1.3Income tax, Q3 FY2024, three months to 2024-09-30$1.3m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure0.6Income tax, Q4 FY2024, three months to 2024-12-31$648.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure0.9Income tax, Q1 FY2025, three months to 2025-03-31$852.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure2.5Income tax, Q2 FY2025, three months to 2025-06-30$2.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure(0.7)Income tax, Q3 FY2025, three months to 2025-09-30−$733.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure1.1Income tax, Q4 FY2025, three months to 2025-12-31$1.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure0.6Income tax, Q1 FY2026, three months to 2026-03-31$623.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure(0.7)Income tax, Q2 FY2026, three months to 2026-06-30−$714.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Net income$m(93.0)Net income, Q3 FY2023, three months to 2023-09-30−$93.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure(49.0)Net income, Q4 FY2023, three months to 2023-12-31−$49.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure(59.9)Net income, Q1 FY2024, three months to 2024-03-31−$59.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure(37.9)Net income, Q2 FY2024, three months to 2024-06-30−$37.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure(35.8)Net income, Q3 FY2024, three months to 2024-09-30−$35.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure(49.0)Net income, Q4 FY2024, three months to 2024-12-31−$49.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure(34.4)Net income, Q1 FY2025, three months to 2025-03-31−$34.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure34.5Net income, Q2 FY2025, three months to 2025-06-30$34.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure(27.5)Net income, Q3 FY2025, three months to 2025-09-30−$27.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure(16.3)Net income, Q4 FY2025, three months to 2025-12-31−$16.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure(13.5)Net income, Q1 FY2026, three months to 2026-03-31−$13.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure(17.9)Net income, Q2 FY2026, three months to 2026-06-30−$17.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Diluted EPS$ per share(0.79)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figurenot reported(0.50)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure(0.32)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure(0.30)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figurenot reported(0.28)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure0.28Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure(0.22)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figurenot reported(0.10)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure(0.14)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Basic EPS$ per share(0.79)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.79 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figurenot reported(0.50)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure(0.32)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure(0.30)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.30 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figurenot reported(0.28)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure0.28Basic EPS, Q2 FY2025, three months to 2025-06-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure(0.22)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figurenot reported(0.10)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure(0.14)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure

Balance sheet

Cash and equivalents$344.1m, FY2024
Shareholders' equity$825.5m, Q2 FY2026
10x Genomics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported359Cash and equivalents, FY2023, at 2023-12-31$359.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-13, accession 0001770787-25-000013.Report this figurenot reportednot reportednot reported344Cash and equivalents, FY2024, at 2024-12-31$344.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-13, accession 0001770787-25-000013.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Current assets$m562Current assets, Q3 FY2023, at 2023-09-30$562.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-03, accession 0001770787-23-000053.Report this figure596Current assets, FY2023, at 2023-12-31$596.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-13, accession 0001770787-25-000013.Report this figure567Current assets, Q1 FY2024, at 2024-03-31$567.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-04-30, accession 0001770787-24-000036.Report this figure579Current assets, Q2 FY2024, at 2024-06-30$579.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-08, accession 0001770787-24-000060.Report this figure594Current assets, Q3 FY2024, at 2024-09-30$593.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure584Current assets, FY2024, at 2024-12-31$584.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-13, accession 0001628280-26-007822.Report this figure580Current assets, Q1 FY2025, at 2025-03-31$579.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure656Current assets, Q2 FY2025, at 2025-06-30$655.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure660Current assets, Q3 FY2025, at 2025-09-30$659.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure684Current assets, FY2025, at 2025-12-31$684.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure670Current assets, Q1 FY2026, at 2026-03-31$669.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure675Current assets, Q2 FY2026, at 2026-06-30$674.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Total assets$m949Total assets, Q3 FY2023, at 2023-09-30$948.5m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0001770787-23-000053.Report this figure965Total assets, FY2023, at 2023-12-31$965.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-13, accession 0001770787-25-000013.Report this figure923Total assets, Q1 FY2024, at 2024-03-31$922.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-04-30, accession 0001770787-24-000036.Report this figure930Total assets, Q2 FY2024, at 2024-06-30$929.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-08, accession 0001770787-24-000060.Report this figure938Total assets, Q3 FY2024, at 2024-09-30$937.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure919Total assets, FY2024, at 2024-12-31$918.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-13, accession 0001628280-26-007822.Report this figure903Total assets, Q1 FY2025, at 2025-03-31$903.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure980Total assets, Q2 FY2025, at 2025-06-30$980.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure1,027Total assets, Q3 FY2025, at 2025-09-30$1.03bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure1,041Total assets, FY2025, at 2025-12-31$1.04bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure1,016Total assets, Q1 FY2026, at 2026-03-31$1.02bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure1,030Total assets, Q2 FY2026, at 2026-06-30$1.03bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Current liabilities$m105Current liabilities, Q3 FY2023, at 2023-09-30$104.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-03, accession 0001770787-23-000053.Report this figure127Current liabilities, FY2023, at 2023-12-31$127.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-13, accession 0001770787-25-000013.Report this figure109Current liabilities, Q1 FY2024, at 2024-03-31$108.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-04-30, accession 0001770787-24-000036.Report this figure111Current liabilities, Q2 FY2024, at 2024-06-30$111.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-08, accession 0001770787-24-000060.Report this figure121Current liabilities, Q3 FY2024, at 2024-09-30$121.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure118Current liabilities, FY2024, at 2024-12-31$117.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-13, accession 0001628280-26-007822.Report this figure108Current liabilities, Q1 FY2025, at 2025-03-31$107.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure112Current liabilities, Q2 FY2025, at 2025-06-30$112.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure147Current liabilities, Q3 FY2025, at 2025-09-30$147.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure153Current liabilities, FY2025, at 2025-12-31$153.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure114Current liabilities, Q1 FY2026, at 2026-03-31$113.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure119Current liabilities, Q2 FY2026, at 2026-06-30$118.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Total liabilities$m203Total liabilities, Q3 FY2023, at 2023-09-30$203.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-03, accession 0001770787-23-000053.Report this figure224Total liabilities, FY2023, at 2023-12-31$224.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-13, accession 0001770787-25-000013.Report this figure204Total liabilities, Q1 FY2024, at 2024-03-31$204.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-04-30, accession 0001770787-24-000036.Report this figure206Total liabilities, Q2 FY2024, at 2024-06-30$205.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-08, accession 0001770787-24-000060.Report this figure215Total liabilities, Q3 FY2024, at 2024-09-30$215.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure209Total liabilities, FY2024, at 2024-12-31$208.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-13, accession 0001628280-26-007822.Report this figure196Total liabilities, Q1 FY2025, at 2025-03-31$196.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure207Total liabilities, Q2 FY2025, at 2025-06-30$206.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure242Total liabilities, Q3 FY2025, at 2025-09-30$242.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure245Total liabilities, FY2025, at 2025-12-31$245.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure201Total liabilities, Q1 FY2026, at 2026-03-31$201.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure205Total liabilities, Q2 FY2026, at 2026-06-30$204.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m745Shareholders' equity, Q3 FY2023, at 2023-09-30$745.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure741Shareholders' equity, FY2023, at 2023-12-31$741.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-13, accession 0001628280-26-007822.Report this figure719Shareholders' equity, Q1 FY2024, at 2024-03-31$718.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure724Shareholders' equity, Q2 FY2024, at 2024-06-30$724.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure723Shareholders' equity, Q3 FY2024, at 2024-09-30$722.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure710Shareholders' equity, FY2024, at 2024-12-31$710.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure707Shareholders' equity, Q1 FY2025, at 2025-03-31$706.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure773Shareholders' equity, Q2 FY2025, at 2025-06-30$773.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure785Shareholders' equity, Q3 FY2025, at 2025-09-30$785.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure796Shareholders' equity, FY2025, at 2025-12-31$796.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure814Shareholders' equity, Q1 FY2026, at 2026-03-31$814.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure826Shareholders' equity, Q2 FY2026, at 2026-06-30$825.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure

Cash flow

Operating cash flow$17.0m, Q2 FY2026
Capital expenditure$1.6m, Q2 FY2026
10x Genomics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(25.3)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$25.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-29, accession 0001770787-24-000073. Derived: 9-month figure less the 6-month figure.Report this figure25.8Operating cash flow, Q4 FY2023, three months to 2023-12-31$25.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure(15.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure7.5Operating cash flow, Q2 FY2024, three months to 2024-06-30$7.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-08, accession 0001770787-25-000051. Derived: 6-month figure less the 3-month figure.Report this figure21.6Operating cash flow, Q3 FY2024, three months to 2024-09-30$21.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001628280-25-050332. Derived: 9-month figure less the 6-month figure.Report this figure(6.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure34.4Operating cash flow, Q1 FY2025, three months to 2025-03-31$34.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure17.7Operating cash flow, Q2 FY2025, three months to 2025-06-30$17.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001628280-26-054491. Derived: 6-month figure less the 3-month figure.Report this figure43.2Operating cash flow, Q3 FY2025, three months to 2025-09-30$43.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001628280-25-050332. Derived: 9-month figure less the 6-month figure.Report this figure40.8Operating cash flow, Q4 FY2025, three months to 2025-12-31$40.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure26.1Operating cash flow, Q1 FY2026, three months to 2026-03-31$26.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure17.0Operating cash flow, Q2 FY2026, three months to 2026-06-30$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-07, accession 0001628280-26-054491. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m15.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$15.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-29, accession 0001770787-24-000073. Derived: 9-month figure less the 6-month figure.Report this figure3.5Capital expenditure, Q4 FY2023, three months to 2023-12-31$3.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure2.9Capital expenditure, Q1 FY2024, three months to 2024-03-31$2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure2.9Capital expenditure, Q2 FY2024, three months to 2024-06-30$2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-08, accession 0001770787-25-000051. Derived: 6-month figure less the 3-month figure.Report this figure3.9Capital expenditure, Q3 FY2024, three months to 2024-09-30$3.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001628280-25-050332. Derived: 9-month figure less the 6-month figure.Report this figure2.7Capital expenditure, Q4 FY2024, three months to 2024-12-31$2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure1.9Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure1.6Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001628280-26-054491. Derived: 6-month figure less the 3-month figure.Report this figure0.7Capital expenditure, Q3 FY2025, three months to 2025-09-30$687.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001628280-25-050332. Derived: 9-month figure less the 6-month figure.Report this figure1.8Capital expenditure, Q4 FY2025, three months to 2025-12-31$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-13, accession 0001628280-26-007822. Derived: 12-month figure less the 9-month figure.Report this figure1.6Capital expenditure, Q1 FY2026, three months to 2026-03-31$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure1.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-07, accession 0001628280-26-054491. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)129.98m, Q2 FY2026
10x Genomics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares114Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30114,112,382 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0001770787-23-000053.Report this figure116Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31115,619,869 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-04-30, accession 0001770787-24-000036.Report this figure117Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30116,707,672 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-08, accession 0001770787-24-000060.Report this figure118Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30117,728,293 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-29, accession 0001770787-24-000073.Report this figure119Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31119,394,180 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-09, accession 0001770787-25-000032.Report this figure120Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30120,066,972 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-08, accession 0001770787-25-000051.Report this figure121Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30120,733,030 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure123Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31122,606,091 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure125Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30124,509,720 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure126Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30125,502,291 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001628280-25-050332.Report this figure128Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31128,291,153 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001628280-26-032388.Report this figure130Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30129,984,169 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-07, accession 0001628280-26-054491.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. Listed shows no prices and gives no investment advice.